MichaelDerekRothMD

Critical Care Medicine, Pleural Disease

Professor, Medicine, UCLA School of Medicine

Dr. Roth is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
UCLA Medical Center
200 UCLA Medical Plaza, Suite 365B
Los Angeles, CA 90095
Phone+1 310-825-8061

Fax+1 310-825-8061

UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 1986 - 1989
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 1983 - 1986
David Geffen School of Medicine at UCLAClass of 1983

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

PubMed

2 citations
Hyaluronidase Enhances Targeting of Hydrogel-Encapsulated Anti-CTLA-4 to Tumor Draining Lymph Nodes and Improves Anti-Tumor Efficacy.
Airi Harui, Michael D Roth
Gels. 2022-05-03
12 citations
Early Radiographic Progression of Scleroderma: Lung Disease Predicts Long-term Mortality.
Elizabeth R Volkmann, Donald P Tashkin, Michael D Roth, Jonathan Goldin, Grace H J Kim
Chest. 2022-05-01
2 citations
High 68 Ga-FAPI-46 uptake in a pulmonary necrotizing granuloma in a patient with subcutaneous lipoma.
Masatoshi Hotta, Matthias R. Benz, Martin Allen-Auerbach, Joseph G. Crompton, Michael D. Roth
European Journal of Nuclear Medicine and Molecular Imaging. 2021-09-21

UCLA Receives $6.4 Million to Fund Cannabis ResearchNovember 19th, 2020
Phase 2 Trial of CellCept plus Esbriet for SSc-ILD Enrolling in USAugust 31st, 2020
Antihypertensive Drugs and Risk of COVID-19?March 26th, 2020

Evaluating Effects Of Marijuana Smoking Ability To Respond To Hepatitis B VaccinNational Center For Research Resources2009–2010
Pulmonary And Immunologic Effects Of Marijuana Use On HIV And Viral ImmunityNational Institute On Drug Abuse2007–2010
Cytokines As Predictors Of Disease Progression In Scleroderma Lung DiseaseNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2007–2009
Cocaine Smoking Effects On The Lung Immunity And Host Defense: HIVNational Center For Research Resources2007
Vector-Based Generation Of Monoclonal Antibodies Against The CB2 ReceptorNational Institute On Drug Abuse2006–2007
Pulmonary Effects Of Habitual Use Of MarijuanaNational Institute On Drug Abuse2006
Effects Of Marijuana On HIV And Viral ImmunityNational Institute On Drug Abuse2006
Cocaine Smoking Effects On Lung Immunity &Host DefenseNational Institute On Drug Abuse2005–2006
Adjuvant Immunotherapy For Non-Small Cell Lung CancerNational Cancer Institute2004–2005
Core--Clinical TrialsNational Cancer Institute2001–2002
Career Development ProgramNational Cancer Institute2001–2002
Clinical Centers For Feasibility Studies On Retinoid TREDivision Of Lung Diseases1999–2000
Cytotoxic Cell Regulation By The Pulmonary MacrophageNational Cancer Institute1990–1992